needed effects
quinidine
unwanted side effects
medical attention
following side effects
taking quinidine
check
doctor
quinidine side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
cinchonism
severe depending on symptoms
mild cinchonism
symptoms
blurred vision
transient deafness
anorexia
nausea
weakness
vertigo
tinnitus
diarrhea
headache
mild cinchonism
higher dosages
further quinidine therapy
moderate cinchonism
vomiting
hypotension
qrs duration
rare premature ventricular contractions
severe cinchonism
myocardial toxicity
malignant arrhythmias
qrs duration
high degree av heart block
cardiac arrest
quinidine
side effects
gastrointestinal complaints
myocardial toxicity
reported symptoms
been diarrhea
nausea
vomiting
risk of toxicity
plasma quinidine concentrations
mg/l
dose-related cinchonism
first sign of quinidine toxicity
cinchonism
syndrome
cinchona alkaloids
including quinidine
sign of chronic toxicity
single moderate dose in sensitive patients
cardiovascular
side effects
hypotension
syncope
qrs duration
msec
myocardial toxicity
tachyarrhythmia
patients
quinidine-induced long qt syndrome
rare cases of torsades de pointes
myocardial toxicity
malignant arrhythmias
qrs duration of greater
high degree av heart block
cardiac arrest
quinidine
stroke volume
cardiac output
routine use
following myocardial infarction
view of the cardiac arrhythmia suppression trial
cast
data
use of quinidine
atrial fibrillation in patients with chronic atrial fibrillation
controlled study
comparing quinidine
placebo
difference in efficacy
demonstrable reduction in overall mortality in treated patients
crude mortality rate
patients
quinidine
patients
placebo
gastrointestinal side effects
reported adverse effects
anorexia
nausea
vomiting
diarrhea
patients
quinidine pill esophagitis
nausea
vomiting
diarrhea
part of the cinchonism syndrome
dose-related quinidine toxicity
year-old man
progressive dysphagia
solids during quinidine therapy
upper endoscopy
proximal narrowing
findings of cancer
infection
quinidine pill esophagitis
drug
lesion
month
nervous system
side effects
dizziness
headache
tremor
nervousness
coordination difficulties
such symptoms
part of the cinchonism syndrome
signs of quinidine toxicity
anticholinergic activity of quinidine
myasthenia gravis
convulsions
association with quinidine
year-old man with atrial flutter
drowsiness
emesis
icterus
elevated liver function tests
marked centrilobular cholestasis with mild bile duct inflammation per liver biopsy
days
beginning quinidine therapy
evidence of biliary obstruction per ultrasound
signs
symptoms of hepatitis
discontinuation of quinidine
year-old man with paroxysmal atrial fibrillation
fever
lethargy
nausea
abdominal pain
elevated liver function tests
serological evidence of a viral etiology
days
beginning quinidine therapy
liver biopsy
signs
symptoms of hepatitis
days after discontinuation of quinidine
rare cases of reversible granulomatous hepatitis
presenting as fever
urticarial rash
elevated liver function tests
mild thrombocytopenia
quinidine
long-term study of patients with a history of quinidine-associated hepatitis
persistent liver function abnormalities
hepatic toxicity
quinidine
hypersensitivity
quinidine
hypersensitivity-induced hepatitis
patients
weeks of therapy
jaundice occurred rarely.
resolution
most cases
weeks
following discontinuation
cases
granulomatous hepatitis
ocular side effects
mydriasis
color perception changes
night blindness
scotomata
optic neuritis
visual field loss
blurred vision
diplopia
photophobia
part of the dose-related cinchonism syndrome
quinidine keratopathy
rare ocular side effect
year-old man with coronary artery disease
photophobia
vision
taking quinidine
metoprolol
furosemide
isosorbide
digoxin
slit-lamp examination
superficial granular deposits within the corneal epithelium
epithelial surface
fluorescein upon staining
corneal deposits
months
discontinuing quinidine
hematologic abnormalities
leukopenia
thrombocytopenia
rare cases of leukocytosis
cases of an igg antibody
presence of quinidine
activity against leukocytes
platelets
cases
significant infection
hemorrhage
year-old man
malaise
weakness
chills
oral ulcerations
days
beginning quinidine
digoxin for atrial fibrillation
laboratory examination
low leukocyte count
bone marrow aspiration
hypocellular myeloid line
neutrophil count
baseline
days after discontinuation of quinidine
continuation of digoxin
authors
other such cases in a review of medical literature
year-old man
malaise
extensive maculopapular rash
palpable purpura
mental status changes
rigors
nausea
night sweats during therapy with quinidine
digoxin
laboratory findings
proteinuria
elevated liver function tests
eosinophilia
elevated antinuclear antibody titer
renal biopsy findings
allergic granulomatous angiitis
syndrome
following quinidine discontinuation
steroid therapy
allergic reactions
digoxin
authors
implicated quinidine
rechallenge
year-old man with a history of atrial fibrillation
digoxin
quinidine sulfate
fever
malaise
nodular infiltrates on chest x-ray
condition
treatment with an oral cephalosporin
diagnostic evaluation
heart failure
tests for typical
atypical infections
pulmonary function testing
mild restriction
days
stopping quinidine
signs
symptoms of pneumonitis
bronchoalveolar lavage
transbronchial biopsy
changes
allergic pneumonitis
quinidine
recurrent signs
symptoms of allergic pneumonitis
hypersensitivity-induced hepatitis
patients
weeks of therapy
hypersensitivity reactions
uveitis
allergic vasculitis
lymphadenopathy
hemolytic anemia
thrombocytopenia
agranulocytosis
bronchospasm
pneumonitis
photosensitive dermatitis psoriaform rash
angioedema
sicca syndrome
arthralgia
myalgia
elevated levels of skeletal muscle enzymes
dermatologic side effects
photosensitive rashes
psoriasis
abnormal pigmentation
actinic dermatitis
quinidine
possible cause of lichen planus in susceptible patients
year-old man with premature ventricular depolarizations
papular rash
back
chest
resolution
weeks of discontinuation of therapy
patient
other oral medications
year-old man
bluish-grey discoloration
skin
oral mucosa
nailbeds
months
following discontinuation of quinidine
other medications
year-old man with a history of convalescent psoriasis vulgaris
exacerbation of psoriasis within hours
initiating quinidine therapy
psoriasis
aggressive puva therapy
quinidine
cases of quinidine-induced systemic lupus erythematosus
majority of patients
gender difference
frequent complaint
polyarthralgias
immunologic side effects
systemic lupus erythematosus
quinidine therapy
rare cases of quinidine-induced polyarthropathy without development of antinuclear antibodies
renal side effects
rare reports of quinidine-induced nephrotic syndromes
year-old woman
edema
proteinuria
grams per hours
hypercholesterolemia
elevated complement levels
elevated antinuclear antibody titers
months
beginning digoxin
quinidine
signs of the nephrotic syndrome
days after discontinuation of quinidine
continuation of digoxin
quinidine
fatigue
myalgias
arthralgias
anorexia
weakness
author
case
quinidine-induced nephrotic syndrome
quinidine-induced lupus
erythematosus-like illness
renal disease
year-old man
receiving allopurinol for gout
progressive uremia
proteinuria
edema
purpura
beginning quinidine therapy
patient
required hemodialysis
progressive glomerulonephritis
macrophage migration-inhibition test
presence of both quinidine
allopurinol
such tests
presence of uremia
authors
quinidine
henoch-schonlein purpura in this patient
chronologic association
lack of allopurinol-associated problems
following chronic therapy
year-old man with supraventricular tachycardia
visual hallucinations
delusions
psychomotor agitation within minutes of the initial dose of quinidine
serum quinidine level at the time
mg/l
mg/l
patient
mental status
baseline after discontinuation of quinidine
year-old man with a supraventricular arrhythmia
hypertension
psychosis
psychomotor hyperactivity
hours
starting quinidine
serum quinidine level at the time
mg/l
mg/l
patient
mental status
baseline after discontinuation of quinidine
psychiatric side effects of depression
quinidine
rare cases of acute psychosis
psychomotor agitation
subtherapeutic quinidine levels in elderly patients
musculoskeletal effects
case of profound musculoskeletal weakness
year-old woman with paroxysmal atrial fibrillation
progressive proximal limb muscle weakness
weeks
starting quinidine
symptoms
discontinuation of therapy
rechallenge
recurrent weakness
diffuse
pruritic rash
diagnostic evaluation
evidence of myasthenia gravis
side effects of quinidine
fda
healthcare professional for medical advice
abdominal pain
yellow eyes
skin
double vision
confusion
delirium
disturbed color perception
headache
noises
ringing in the ear
visual intolerance of light
dizziness or lightheadedness
fainting
fever
chest pain
fever
general discomfort
joint pain
joint swelling
muscle pain
skin rash
nosebleeds
bleeding gums
unusual tiredness
weakness
pale skin
diarrhea
loss of appetite
muscle weakness
nausea or vomiting 